Last updated on May 2018

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)

Brief description of study

The primary objective of this study is to show superiority of vilaprisan in the treatment of heavy menstrual bleeding (HMB) in subjects with uterine fibroids compared to placebo.

The secondary objectives of this study are to additionally evaluate the efficacy and safety of vilaprisan in subjects with uterine fibroids.

Clinical Study Identifier: NCT03400956

Find a site near you

Start Over

Kyoto city Hospital

Nakagyo-ku, Japan
  Connect »

Kusatsu General Hospital

Kusatsu, Japan
  Connect »